There is no fund objective available from this fund manager.
Name | % Net Assets |
---|---|
Progressive | 4.9% |
Berkshire Hathaway | 4.6% |
Johnson & Johnson | 4.5% |
Walgreen | 4.5% |
Oracle Corp | 3.8% |
Merck | 3.7% |
Wal-Mart Stores | 3.7% |
Baxter International | 3.7% |
Bristol Myers Squibb | 3.6% |
Kroger | 3.3% |
Key | % Net Assets |
---|---|
![]() |
4.9% |
![]() |
4.6% |
![]() |
4.5% |
![]() |
4.5% |
![]() |
81.5% |
Date | 25-Apr-2025 |
---|---|
NAV | 1,687.00p |
Currency | GBP |
Change | 67.00p |
% | 4.14% |
YTD change | -277.00p |
YTD % | -14.10% |
Fund Inception | n/a |
---|---|
Fund Manager | Mick Brewis |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.10 |
You are here: research